Assessment of Atrophogenic Potential of Triple Combination Cream for Treatment of Melasma
NCT00469183
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
70
Enrollment
INDUSTRY
Sponsor class
Conditions
Melasma
Interventions
DRUG:
Fluocinolone acetonide .1%, hydroquinone 4%, tretinoin .05%
Sponsor
Galderma R&D